TrialBone marrow transplantation2017

Safety of pre-emptive donor lymphocyte infusions (DLI) based on mixed chimerism (MC) in peripheral blood or bone marrow subsets in children undergoing hematopoietic stem cell transplant (HSCT) for hematologic malignancies.

A Liou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.